ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,445, issued on Feb. 10, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).
"Methods for treatment using anti-Alpha4Beta7 antibody" was invented by Catherine Scholz (North Reading, Mass.) and Irving H. Fox (Dedham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Antibody formulations are described comprising a mixture of a non-reducing sugar, an anti-Alpha4Beta7 antibody and at least one amino acid. The disclosed formulations have improved stability, reduced aggregate formation, and may retard degradation of the anti-Alpha4Beta7 antibody therein or exhibit any combinations thereof. The present invention further provides a safe dosing...